Join to View Full Profile
10201 Grosvenor PlApt 901Rockville, MD 20852
Phone+1 240-423-7348
Dr. Perl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2008
- Ben Gurion University of the NegevClass of 1999
Certifications & Licensure
- MD State Medical License 2007 - 2025
Clinical Trials
- Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols Start of enrollment: 2009 Aug 06
- Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- 3 citationsAcute and persistent responses after H5N1 vaccination in humans.Richard Apps, Angélique Biancotto, Julián Candia, Yuri Kotliarov, Shira Perl
Cell Reports. 2024-09-24 - 8 citationsCombination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial.Hiddo J L Heerspink, Austin G Stack, Robert Terkeltaub, Niels Jongs, Lesley A Inker
Journal of the American Society of Nephrology. 2024-05-01 - 2 citationsVerinurad does not prolong QTc interval: a thorough QT study using concentration-QTc modelling.Joanna Parkinson, Corina Dota, Christian Källgren, Christer Gottfridsson, Magnus Bjursell
British Journal of Clinical Pharmacology. 2023-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: